Paul Capital grows medical royalties franchise

The US secondary specialist is looking to raise E750m for its second royalty acquisition fund, a field that remains uncharted territory for private equity investors.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this